pyridoxal phosphate has been researched along with Chronic Illness in 22 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Conflicting data have been reported concerning the independent association between proteinuria and plasma total homocysteine (tHcy) levels, particularly among chronic renal disease (CRD) patients with a normal range serum creatinine." | 7.71 | Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. ( Bostom, AG; Jacques, PF; König, P; Kraatz, G; Kronenberg, F; Kuen, E; Lhotta, K; Mann, JF; Müller, GA; Neyer, U; Riegel, W; Riegler, P; Ritz, E; Schwenger, V; Selhub, J, 2001) |
| "The effectiveness of combined phenazepam, lithium, haloperidol and metabolic drugs (alpha-tocopherol, pyridoxal phosphate, nicotinamide) treatment of patients with slow progredient schizophrenia is analyzed." | 7.67 | [Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia]. ( Kadysheva, NM; Kryzhanovskiĭ, GN; Mokhovikov, AN; Mosketi, KV, 1988) |
| "Conflicting data have been reported concerning the independent association between proteinuria and plasma total homocysteine (tHcy) levels, particularly among chronic renal disease (CRD) patients with a normal range serum creatinine." | 3.71 | Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. ( Bostom, AG; Jacques, PF; König, P; Kraatz, G; Kronenberg, F; Kuen, E; Lhotta, K; Mann, JF; Müller, GA; Neyer, U; Riegel, W; Riegler, P; Ritz, E; Schwenger, V; Selhub, J, 2001) |
| "The effectiveness of combined phenazepam, lithium, haloperidol and metabolic drugs (alpha-tocopherol, pyridoxal phosphate, nicotinamide) treatment of patients with slow progredient schizophrenia is analyzed." | 3.67 | [Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia]. ( Kadysheva, NM; Kryzhanovskiĭ, GN; Mokhovikov, AN; Mosketi, KV, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (59.09) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Guarnieri, V | 1 |
| Sileri, F | 1 |
| Indirli, R | 1 |
| Guabello, G | 1 |
| Longhi, M | 1 |
| Dito, G | 1 |
| Verdelli, C | 1 |
| Corbetta, S | 1 |
| Kimura, H | 1 |
| Meguro, T | 1 |
| Badr, A | 1 |
| Zhang, JH | 1 |
| Talwar, D | 1 |
| Quasim, T | 1 |
| McMillan, DC | 1 |
| Kinsella, J | 1 |
| Williamson, C | 1 |
| O'Reilly, DS | 1 |
| McCleskey, EW | 1 |
| Korotkiĭ, NG | 1 |
| Udzhukhu, VIu | 1 |
| Borisenko, KK | 1 |
| Michurina, EA | 1 |
| Savkina, AS | 1 |
| Gehl, HB | 1 |
| Günther, RW | 1 |
| Klever, P | 1 |
| Hauptmann, S | 1 |
| Diehl, SJ | 1 |
| Lehmann, KJ | 1 |
| Gaa, J | 1 |
| McGill, S | 1 |
| Hoffmann, V | 1 |
| Georgi, M | 1 |
| Okada, H | 1 |
| Moriwaki, K | 1 |
| Kanno, Y | 1 |
| Sugahara, S | 1 |
| Nakamoto, H | 1 |
| Yoshizawa, M | 1 |
| Suzuki, H | 1 |
| Bostom, AG | 1 |
| Kronenberg, F | 1 |
| Jacques, PF | 1 |
| Kuen, E | 1 |
| Ritz, E | 1 |
| König, P | 1 |
| Kraatz, G | 1 |
| Lhotta, K | 1 |
| Mann, JF | 1 |
| Müller, GA | 1 |
| Neyer, U | 1 |
| Riegel, W | 1 |
| Schwenger, V | 1 |
| Riegler, P | 1 |
| Selhub, J | 1 |
| Guseĭnova, RS | 1 |
| Rossouw, JE | 2 |
| Labadarios, D | 2 |
| Davis, M | 2 |
| Williams, R | 2 |
| McConnell, JB | 1 |
| Pierce, HI | 1 |
| McGuffin, RG | 1 |
| Hillman, RS | 1 |
| Hines, JD | 1 |
| Rosalki, SB | 1 |
| Bayoumi, RA | 1 |
| Vech, RL | 1 |
| Lumeng, L | 1 |
| Li, TK | 1 |
| Lagutina, LE | 1 |
| Utts, IA | 1 |
| Yamada, M | 1 |
| Otani, Y | 1 |
| Azuma, T | 1 |
| Amakawa, T | 1 |
| Kadysheva, NM | 1 |
| Mokhovikov, AN | 1 |
| Mosketi, KV | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Vermaak, WJ | 1 |
| Barnard, HC | 1 |
| Potgieter, GM | 1 |
| Marx, JD | 1 |
| Dobbelstein, H | 1 |
| Körner, WF | 1 |
| Mempel, W | 1 |
| Grosse-Wilde, H | 1 |
| Edel, HH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Micronutrient Deficiencies in Children and Infants With Congenital Heart Diseases (CHD) Admitted for Cardiac Surgery: A Proof-of-concept Study[NCT02409706] | 50 participants (Actual) | Observational | 2014-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pyridoxal phosphate and Chronic Illness
| Article | Year |
|---|---|
Pyridoxine and its metabolism in chronic liver disease.
Topics: Alcoholism; Chemical and Drug Induced Liver Injury; Chronic Disease; Humans; Liver; Liver Diseases; | 1977 |
3 trials available for pyridoxal phosphate and Chronic Illness
| Article | Year |
|---|---|
[Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Chronic Disease; Contrast Media; Edetic Acid; Humans; Magnetic | 1993 |
MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Chronic Disease; Contrast Media; Diagnosis, Differential; Ed | 1999 |
Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin.
Topics: Chronic Disease; Diabetic Neuropathies; Erythropoietin; Female; Glomerulonephritis; Humans; Kidney F | 2000 |
18 other studies available for pyridoxal phosphate and Chronic Illness
| Article | Year |
|---|---|
Clinical, biochemical and genetic findings in adult patients with chronic hypophosphatasemia.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Bone Diseases, Metabolic; Chronic Disease; Cross-Sec | 2022 |
Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Chronic Disease; Dogs; Female; Male; Oxyhemo | 2002 |
Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response.
Topics: Adult; Aged; C-Reactive Protein; Chromatography, High Pressure Liquid; Chronic Disease; Critical Ill | 2003 |
Neurobiology: new player in pain.
Topics: Animals; Chronic Disease; Microglia; Pain; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; | 2003 |
[Treatment of chronic recurrent dermatoses with pyridoxal phosphate].
Topics: Adolescent; Adult; Aged; Chronic Disease; Eczema; Female; Humans; Lichen Planus; Male; Middle Aged; | 1982 |
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.
Topics: Adult; Aged; Chronic Disease; Creatinine; Female; Folic Acid; Glomerular Filtration Rate; Homocystei | 2001 |
[Tryptophan metabolic indices in allergic dermatoses].
Topics: Chronic Disease; Dermatitis, Atopic; Female; Humans; Kynurenic Acid; Kynurenine; Male; Prurigo; Pyri | 1979 |
Vitamin B6 and aspartate aminotransferase activity in chronic liver disease.
Topics: Aspartate Aminotransferases; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Necrosis; Pyr | 1978 |
Vitamin B6 deficiency in chronic liver disease--evidence for increased degradation of pyridoxal-5'-phosphate.
Topics: Alcoholism; Chronic Disease; Humans; Liver Diseases; Pyridoxal Phosphate; Pyridoxic Acid; Pyridoxine | 1977 |
Clinical studies in alcoholic sideroblastosis.
Topics: Adult; Aged; Alcoholism; Anemia, Sideroblastic; Chronic Disease; Diet; Erythropoiesis; Ethanol; Foli | 1976 |
Hematologic abnormalities involving vitamin B6 and folate metabolism in alcoholic subjects.
Topics: Alcoholism; Chronic Disease; Diet Therapy; Enzyme Inhibitors; Erythrocytes; Ethanol; Female; Folic A | 1975 |
Activation by pyridoxal 5-phosphate of aspartate transaminase in serum of patients with heart and liver disease.
Topics: Aspartate Aminotransferases; Chronic Disease; Clinical Enzyme Tests; Enzyme Activation; Humans; Live | 1975 |
Vitamin B6 metabolism in chronic alcohol abuse The effect of ethanol oxidation on hepatic pyridoxal 5'-phosphate metabolism.
Topics: Acute Disease; Alcoholic Intoxication; Animals; Chronic Disease; Humans; In Vitro Techniques; Liver; | 1975 |
[Use of microelement and coenzyme preparations in the complex treatment of children with chronic pyelonephritis].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Coenzymes; Copper; Copp | 1991 |
[A case of abnormal GOT].
Topics: Adult; Aspartate Aminotransferases; Chronic Disease; Diagnosis, Differential; Female; Hepatitis; Hum | 1989 |
[Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia].
Topics: Adolescent; Adult; Aged; alpha-Tocopherol; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; | 1988 |
Plasma pyridoxal-5'-phosphate levels in myocardial infarction.
Topics: Cholesterol, HDL; Chronic Disease; Coronary Disease; Fasting; Humans; Middle Aged; Myocardial Infarc | 1986 |
Vitamin B6 deficiency in uremia and its implications for the depression of immune responses.
Topics: Administration, Oral; Aspartate Aminotransferases; Chronic Disease; Creatinine; DNA; Erythrocytes; H | 1974 |